We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

61 hedge funds and large institutions have $297M invested in PTC Therapeutics in 2013 Q3 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

8,460% more capital invested

Capital invested by funds: $3.47M → $297M (+$294M)

5,800% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 1

1,933% more funds holding

Funds holding: 3 → 61 (+58)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
61
Holders Change
+58
Holders Change %
+1,933.33%
% of All Funds
1.98%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
59
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCPEM
Bain Capital Public Equity Management
Massachusetts
+$40.6M
2
CS
Credit Suisse
Switzerland
+$39.2M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$29.5M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$26.3M
5
DM
Deerfield Management
New York
+$14.7M

Top Sellers

1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.93M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$497K
3
ICAP
Independence Capital Asset Partners
Colorado
-$156K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
$97K +$78.2K +4,500 New
SO
52
STRS Ohio
Ohio
$94K +$76.5K +4,400 New
EWM
53
Evercore Wealth Management
New York
$64K +$52.1K +3,000 New
NFA
54
Nationwide Fund Advisors
Ohio
$60K +$48.7K +2,800 New
TRCT
55
Tower Research Capital (TRC)
New York
$20K +$16.3K +937 New
U
56
UBS
Switzerland
$15K +$12.1K +698 New
Barclays
57
Barclays
United Kingdom
$11K +$9.42K +542 New
MTIP
58
Magee Thomson Investment Partners
California
$6K +$4.99K +287 New
BlackRock
59
BlackRock
New York
$4K +$3.48K +200 New
AllianceBernstein
60
AllianceBernstein
Tennessee
$2K +$1.95K +112 New
Manulife (Manufacturers Life Insurance)
61
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3 +$2.83K +163 New
ICAP
62
Independence Capital Asset Partners
Colorado
– -$156K -10,400 Closed
1 2
3

PTCT Hedge Fund Activity: Q3 2013 in Review

61 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q3 2013, worth a combined $297M — up 8,460% from $3.47M a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new PTCT positions and 1 closed out — a net gain of 58 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Bain Capital Public Equity Management, opening a new position worth an estimated $40.6M. The largest seller was Alyeska Investment Group, cutting an estimated $1.93M.

  • 61 institutional investors held PTC Therapeutics (PTCT) as of Q3 2013, up from 3 in Q2 2013.
  • Funds reported $297M of PTC Therapeutics stock for Q3 2013, up 8,460% quarter-over-quarter.
  • 59 funds opened new PTC Therapeutics positions in Q3 2013 and 1 closed out, a net change of +58 holders.
  • The largest PTC Therapeutics buyer in Q3 2013 was Bain Capital Public Equity Management, an estimated $40.6M added.
  • The largest PTC Therapeutics seller in Q3 2013 was Alyeska Investment Group, an estimated $1.93M sold.

Based on aggregated 13F filings for Q3 2013.